LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1097 | 3485 | 3846 | 0.9055 | 0.8924 |
BT-20 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3391 | 3846 | 0.8812 | 0.8641 |
BT-20 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2722 | 3846 | 0.7077 | 0.6515 |
BT-20 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1818 | 3846 | 0.4724 | 0.3205 |
BT-20 | HG-5-113-01 | 10 | uM | LJP5 | 72 | hr | 1097 | 934 | 3846 | 0.2426 | -0.0865 |
BT-20 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2905 | 3673 | 0.7914 | 0.7483 |
BT-20 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3491 | 3673 | 0.9503 | 0.9422 |
BT-20 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3375 | 3673 | 0.9194 | 0.9058 |
BT-20 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 3264 | 3673 | 0.8885 | 0.8687 |
BT-20 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3320 | 3673 | 0.9036 | 0.8866 |
BT-20 | HG-5-88-01 | 10 | uM | LJP6 | 72 | hr | 1097 | 1969 | 3673 | 0.5366 | 0.3975 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3336 | 3673 | 0.9080 | 0.8919 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 2796 | 3673 | 0.7610 | 0.7098 |
BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2594 | 3673 | 0.7064 | 0.6385 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 72 | hr | 1097 | 2050 | 3673 | 0.5584 | 0.4316 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1560 | 3673 | 0.4252 | 0.2241 |
BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1097 | 627 | 3673 | 0.1708 | -0.2747 |
BT-20 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 2893 | 3846 | 0.7515 | 0.7066 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 1097 | 2626 | 3846 | 0.6824 | 0.6184 |
BT-20 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2260 | 3846 | 0.5873 | 0.4890 |
BT-20 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1097 | 2012 | 3846 | 0.5230 | 0.3973 |
BT-20 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1714 | 3846 | 0.4450 | 0.2758 |
BT-20 | Neratinib | 10 | uM | LJP5 | 72 | hr | 1097 | 1416 | 3846 | 0.3685 | 0.1498 |
BT-20 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2963 | 3673 | 0.8073 | 0.7687 |
BT-20 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1097 | 3059 | 3673 | 0.8331 | 0.8010 |